Cite
HARVARD Citation
Staehler, M. et al. (2021). Everolimus after failure of one prior VEGF‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC‐2 trial. International journal of cancer. 148 (7), pp. 1685-1694. [Online].